6850.TWO BiOptic Inc.

Healthcare Biotechnology Taiwan OTC Exchange
28.30 TWD
Close of Nov 6, 2026
28.00 45.31
Market cap
TWD 936M
P/E
104.8x
P/B
2.19x
ROE
4.8%
Dividend yield
0.57%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2025.

Is 6850.TWO undervalued?

Graham number

The Graham number of BiOptic Inc. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BiOptic Inc. fundamental analysis

No fundamental analysis for BiOptic Inc. yet.

BiOptic Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BiOptic Inc.

BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.

Full company profile